Ncardia
Leiden
About Ncardia
Ncardia is an Operator of a biotechnology company intended to expedite drug discovery and development process.The company uses hiPSC stem cell technology to develop predictive human cellular assay systems for safety and efficacy testing of drug candidates as well as enhance cardiovascular and neural drug screening, enabling researchers to bring predictive human disease biology and accelerate drug discovery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $83.7M
- Last round: Series Unknown (Nov 2021)
- Website: ncardia.com
- Phone: (310) 713-3222
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/ncardia-69619 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.